These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10078718)

  • 1. Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures.
    Schachter SC; Vazquez B; Fisher RS; Laxer KD; Montouris GD; Combs-Cantrell DT; Faught E; Willmore LJ; Morris GL; Ojemann L; Bennett D; Mesenbrink P; D'Souza J; Kramer L
    Neurology; 1999 Mar; 52(4):732-7. PubMed ID: 10078718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial.
    Beydoun A; Sachdeo RC; Rosenfeld WE; Krauss GL; Sessler N; Mesenbrink P; Kramer L; D'Souza J
    Neurology; 2000 Jun; 54(12):2245-51. PubMed ID: 10881247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group.
    Glauser TA; Nigro M; Sachdeo R; Pasteris LA; Weinstein S; Abou-Khalil B; Frank LM; Grinspan A; Guarino T; Bettis D; Kerrigan J; Geoffroy G; Mandelbaum D; Jacobs T; Mesenbrink P; Kramer L; D'Souza J
    Neurology; 2000 Jun; 54(12):2237-44. PubMed ID: 10881246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures.
    Sachdeo R; Beydoun A; Schachter S; Vazquez B; Schaul N; Mesenbrink P; Kramer L; D'Souza J
    Neurology; 2001 Sep; 57(5):864-71. PubMed ID: 11552018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy.
    Barcs G; Walker EB; Elger CE; Scaramelli A; Stefan H; Sturm Y; Moore A; Flesch G; Kramer L; D'Souza J
    Epilepsia; 2000 Dec; 41(12):1597-607. PubMed ID: 11114219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial.
    French JA; Baroldi P; Brittain ST; Johnson JK;
    Acta Neurol Scand; 2014 Mar; 129(3):143-53. PubMed ID: 24359313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials.
    Beydoun A
    Pharmacotherapy; 2000 Aug; 20(8 Pt 2):152S-158S. PubMed ID: 10937814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.
    Chadwick DW; Anhut H; Greiner MJ; Alexander J; Murray GH; Garofalo EA; Pierce MW
    Neurology; 1998 Nov; 51(5):1282-8. PubMed ID: 9818846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy.
    Guerreiro MM; Vigonius U; Pohlmann H; de Manreza ML; Fejerman N; Antoniuk SA; Moore A
    Epilepsy Res; 1997 Jun; 27(3):205-13. PubMed ID: 9237055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy.
    Bill PA; Vigonius U; Pohlmann H; Guerreiro CA; Kochen S; Saffer D; Moore A
    Epilepsy Res; 1997 Jun; 27(3):195-204. PubMed ID: 9237054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxcarbazepine, an antiepileptic agent.
    Kalis MM; Huff NA
    Clin Ther; 2001 May; 23(5):680-700; discussion 645. PubMed ID: 11394728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures.
    Koch MW; Polman SK
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006453. PubMed ID: 19821367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxcarbazepine in a monotherapy trial for partial seizures--placebo-controlled studies in neurology: where do they stop?
    Schachter SC; Vazquez B; Fisher RS; Laxer KD; Combs-Cantrell D; Faught E; Willmore LJ; Morris GL; Ojemann L; Montouris GD
    Neurology; 1999 Dec; 53(9):2211-2. PubMed ID: 10599816
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy.
    Christe W; Krämer G; Vigonius U; Pohlmann H; Steinhoff BJ; Brodie MJ; Moore A
    Epilepsy Res; 1997 Mar; 26(3):451-60. PubMed ID: 9127726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxcarbazepine: a review of its use in children with epilepsy.
    Bang L; Goa K
    Paediatr Drugs; 2003; 5(8):557-73. PubMed ID: 12895138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, safety, and tolerability of oxcarbazepine monotherapy.
    Martinez W; Ingenito A; Blakeslee M; Barkley GL; McCague K; D'Souza J
    Epilepsy Behav; 2006 Nov; 9(3):448-56. PubMed ID: 16962380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxcarbazepine versus phenytoin monotherapy for epilepsy.
    Muller M; Marson AG; Williamson PR
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003615. PubMed ID: 16625587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxcarbazepine reduces seizure frequency in a high proportion of patients with both newly diagnosed and refractory partial seizures in clinical practice.
    Pauletto G; Bergonzi P;
    Seizure; 2006 Apr; 15(3):150-5. PubMed ID: 16439165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxcarbazepine in a monotherapy trial for partial seizures--placebo-controlled studies in neurology: where do they stop?
    Cramer JA
    Neurology; 1999 Dec; 53(9):2212-3. PubMed ID: 10599817
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study.
    Baulac M; Patten A; Giorgi L
    Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.